Source: WHO Neuroscience of Psychoactive Substance Use and Dependence, Summary (2004),Global use of psychoactive substances and burden to health, p.21
Table 1. Prevalence of smoking among adults and youths in selected countries
Table 3. Percentage of total global mortality and DALYs attributable to tobacco, alcohol and illicit substances
Depressants – overview of effects
Table 5. Pharmacological treatments for substance dependence
Table 2. Annual prevalence estimates of global illicit substance use, 2000-2001Table 2. Annual prevalence estimates of global illicit substance use, 2000-2001
Figure 3. A terminal button and synapse
Figure 4. Two types of chemical synapses
Table 4. Summary of psychoactive substance effectsTable 4. Summary of psychoactive substance effects
Figure 5. Mesolimbic dopamine pathway
Box 3. Risk and protective factors for substance use
Figure 1. Adult (15+) Per Capita Alcohol Consumption by Development Status
Figure 2. Mechanisms relating psychoactive substance use to health and social problems
Box 4: Types of psychotherapies and behavioural interventions
Box 1: Injecting substance use and HIV/AIDS
Box 2: Criteria for substance use dependence in ICD-10
